DV Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
DV Trading's SLNO Position: Q2 2026 in Review
DV Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 54,000 shares — an estimated $1.81M sold.
DV Trading first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $2.5M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- DV Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- DV Trading sold 54,000 Soleno Therapeutics shares in Q2 2026, an estimated $1.81M.
- DV Trading first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
- DV Trading's Soleno Therapeutics position peaked at $2.5M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.